LCTX institutional holders
LINEAGE CELL THERAPEUTICS IN · 13F, 2026Q2
| Managers holding | 131 |
|---|
| Shares held | 116,520,978 |
|---|
| Reported value | $152.7m |
|---|
| Quarter flows | 35 new, 25 added, 30 trimmed, 34 exited |
|---|
Top 25 holders
| Manager | Shares | Value | % of manager's 13F |
|---|
| BROADWOOD CAPITAL INC | 49,560,992 | $64.9m | 3.4% |
| BlackRock, Inc. | 13,186,895 | $17.3m | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 9,054,918 | $11.9m | 0.0% |
| Defender Capital, LLC. | 6,598,899 | $8.6m | 2.8% |
| GEODE CAPITAL MANAGEMENT, LLC | 5,299,457 | $6.9m | 0.0% |
| RAFFLES ASSOCIATES LP | 5,197,788 | $6.8m | 3.0% |
| FIFTH THIRD BANCORP | 4,600,000 | $6.0m | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 3,018,567 | $4.0m | 0.0% |
| STATE STREET CORP | 2,314,180 | $3.0m | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 1,668,629 | $2.2m | 0.0% |
| NORTHERN TRUST CORP | 1,656,651 | $2.2m | 0.0% |
| MORGAN STANLEY | 1,471,462 | $1.9m | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 1,344,829 | $1.8m | 0.0% |
| MARSHALL WACE, LLP | 1,282,347 | $1.7m | 0.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,273,311 | $1.7m | 0.0% |
| UBS Group AG | 687,051 | $900,036 | 0.0% |
| RED CRANE WEALTH MANAGEMENT, LLC | 597,263 | $782,415 | 0.6% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 577,435 | $756,440 | 0.0% |
| BARCLAYS PLC | 508,668 | $666,354 | 0.0% |
| Squarepoint Ops LLC | 444,774 | $582,654 | 0.0% |
| GOLDMAN SACHS GROUP INC | 433,266 | $567,578 | 0.0% |
| CITADEL ADVISORS LLC | 426,169 | $558,282 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 424,373 | $555,928 | 0.0% |
| Bank of New York Mellon Corp | 391,675 | $513,094 | 0.0% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 304,562 | $398,976 | 0.0% |
Every holder, line by line, and the full history since 2013: yf.Client().holders("LCTX"). LCTX price history · All 13F data
Get a free API keySee history bundlesDownload free samples